Hepatitis E Diagnostic Tests Market New Innovations Trends, and Growth Factor

Global Hepatitis E Diagnostic Tests Market is valued approximately USD 50.00 million in 2019 and is anticipated to grow with a healthy growth rate of more than 4.50 % over the forecast period 2020-2027. Hepatitis E virus is the leading cause of acute viral hepatitis in the world mainly affecting the liver. Hepatitis E virus is considered as travel-associated infection. Diagnosis of HEV is based on the detection of viral RNA in the serums or feces. There is no specific treatment for hepatitis E. Analysis of HEV performed on RNA in biologic specimens such as liver biopsy, stools and serums are used for diagnostics. Further, government and health authority of various countries are also taking various efforts for making diagnostic tests available in the countries. A world Health Organization is focusing in making vaccine and diagnostic test available to reduce the global burden of disease. Also, the key players are focusing on strategies such as product launch, innovation and merger & acquisition to sustain themselves amidst fierce competition.

The growth of the market is attributed owing to the increase in rise in prevalence of hepatitis-e disease along with the government initiative regarding awareness of hepatis E diagnosis. As per the World Health Organizations in July 2020, the WHO estimated that every year there were an estimated 20 million HEV infections worldwide, leading to a 3.3 million symptomatic cases of hepatitis E. As a result, the need for hepatitis e diagnostic tests would increase thereby, reinforcing the growth of the market during the forecast period of 2020-2027. However, high cost of diagnostics procedure and poor reimbursement policies may hinder growth of global Hepatitis E diagnostic tests market.

Click Here to Download Sample Report >> https://www.sdki.jp/sample-request-110305

The regional analysis of global Hepatitis E Diagnostic Tests market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia-pacific is the leading/significant region due to the increasing incidence of Hepatitis E in some countries such as Nepal, Vietnam, Pakistan, Bangladesh, Burma, Kazakhstan, Thailand, and Bhutan of this region. Also, the dominance of the region is witnessed owing to the lack of proper sanitation and access to safe drinking water which may cause Hepatitis E. Whereas Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027.

Major market player included in this report are:
Altona Diagnostics GmbH
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Biokit S.A.
Dia.Pro – Diagnostic Bioprobes s.r.l
F. Hoffmann-La Roche Ltd.
Fast-track diagnostics Ltd.
Fortress Diagnostics Limited
Mikrogen GmBH
MP Biomedicals, LLC.
Primerdesign Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

Share your love
Christophe Rude

Christophe Rude

Articles: 15889

Leave a Reply

Your email address will not be published. Required fields are marked *